Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges

Mohammad Imran Khan1, Suvasmita Rath1, Vaqar Mustafa Adhami1

  • 1Department of Dermatology, University of Wisconsin, Madison, WI 53706, United States.

Pharmacological Research
|December 14, 2017
PubMed

Insights

Dietary bioactive compounds influence epigenetics, impacting gene expression and cancer development. These compounds offer potential for cancer prevention and therapy by modifying the epigenome through mechanisms like DNA methylation and histone modifications.

Area of Science:

  • Epigenetics and Cancer Biology
  • Nutritional Science
  • Molecular Oncology

Background:

  • Tumorigenesis is intricately linked with epigenetic alterations, which regulate gene expression without changing DNA sequence.
  • Epigenetic modifications are heritable and reversible, influencing cellular processes and disease development.
  • Dietary bioactive ingredients are increasingly recognized for their ability to modulate epigenetic mechanisms.

Purpose of the Study:

  • To review recent advancements in understanding the role of dietary bioactive components in epigenetics.
  • To explore how these components influence the human epigenome for cancer prevention and therapy.
  • To highlight the mechanisms by which bioactive compounds modify epigenetic marks.

Main Methods:

  • Literature review of recent studies on dietary bioactive components and epigenetics.
  • Analysis of research on epigenetic modifications including DNA methylation, histone modification, and non-coding RNAs (miRNAs and lncRNAs).
  • Synthesis of findings on the impact of bioactive compounds on cancer development and treatment.

Main Results:

  • Dietary bioactive components can modify the epigenome by targeting DNA methylation and histone modifications.
  • Specific bioactive compounds influence microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), key epigenetic regulators.
  • Evidence supports the role of these dietary factors in both cancer prevention and therapeutic strategies.

Conclusions:

  • Epigenetic regulation by dietary bioactive components presents promising avenues for cancer prevention.
  • Modulating the epigenome with specific nutrients offers potential for novel cancer therapies.
  • Further research into bioactive compounds can lead to targeted epigenetic interventions for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.9K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K